Donate For Public and Patients Store Search

Welcome!

Search


A string of (clinical) pearls about drug-induced linear IgA disease

By Warren R. Heymann, MD Aug. 6, 2018 Linear IgA dermatosis patient with urticarial eruption of the trunk. ... Credit: ... JAAD The late sage Wallace Clark taught me that once a diagnosis is secured, thinking ceases. Admittedly in cases of drug-induced linear IgA dermatosis (DI-LAD) that I have encountered

Session handouts and meetings archive

Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation

Cyclosporine reaches the top of the SJS/TEN leaderboard

By Warren R. Heymann, MD Oct. 16, 2017 ... A, Sheet-like detachment, blisters, and raw erosions on back of patient with Stevens-Johnson syndrome/toxic epidermal necrolysis. B, Postinflammatory hyperpigmentation accentuated in areas where detached epidermis was not left in situ. ... Credit: ... JAAD The first commentary in DI&I for 2017

CME & session evaluation archive

Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023

AADA hosts largest Capitol Hill skin cancer check in a decade

On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.

The rosy reality of coffee

Ronnie and me enjoying our rosacea prevention tour of Madrid in 2012 ... By Warren R. Heymann, MD Nov. 5, 2018 To paraphrase Justice Kavanaugh, I loved coffee. I still love coffee. I have probably been drinking coffee since my time in utero. My mother was a coffee addict; she

Dyeing for a “new” topical agent for psoriasis? Think indigo

By Warren R. Heymann, MD April 9, 2018 Despite the magnificent revolution of biologics for psoriasis, topical agents remain the cornerstone of treatment, either alone, or in combination with phototherapy or systemic treatments. Patients clamor for "natural" products and are increasingly steroid phobic (please see "Countering Corticophobia with Assistance from

What are keratoacanthomatous lesions of the legs in mature women?

By Warren R. Heymann, MD Dec. 11, 2017 ... Right thigh, keratoacanthomatous atypical squamous proliferation. (Hematoxylin-eosin stain; original magnification: ×10.) ... Credit: ... JAAD I have an increasing number of patients asking me questions about proliferating keratoacanthoma-like lesions on their shins. "Why am I getting these? Are they cancer? Why

Does the JAK inhibitor baricitinib raise the bar on treating lupus?

By Warren R. Heymann, MD Aug. 20, 2018 Cutaneous lupus in dermatomal distribution. Erythematous papules in a dermatomal distribution along the patient's left lower extremity. ... Credit: ... JAAD Undeniably, the JAK inhibitors have been at the forefront of advances in immunologically-based diseases, including alopecia areata, vitiligo, psoriasis, rheumatoid arthritis,

Happy 4th of July from DI&I

By Warren R. Heymann, MD July 3, 2018 George Washington contracted smallpox when he was 19 years old. Although he nearly succumbed to the disease, he survived with pockmark scars and life-long immunity. (1) He and other founders recognized the severity of smallpox and its threat to their independence and

PDF of AADA support letter

Honorable Lisa Murkowski The Honorable Tom Udall Chairman Ranking Member Subcommittee on Interior

IA25 Meeting Suites Guidelines

charge to be billed directly through Freeman: • exterior graphic panel to the right of the door • Interior

2025 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) exterior graphic panel to the right of the door • Interior

2026 AAD Annual Meeting | Exhibitor Meeting Suites Guidelines

to be billed directly through Freeman: • (1) Exterior graphic panel to the right of the door • Interior

AAD Event Advertising: Annual Meeting

The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities

Battling bugs...that aren't there

Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists embrace empathy, antipsychotics to help patients with psychocutaneous disease ... Dermatologists embrace empathy, antipsychotics to help patients with psychocutaneous disease ... By Jan Bowers, contributing writer Dermatologists are well equipped to diagnose and treat all manner of

Unrestricted fascination with restrictive dermopathy

By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and

Welcome to Dermatology World Insights and Inquiries

By Warren R. Heymann, MD March 13, 2019 Vol. 1, No. 1 Keeping up with clinically relevant dermatologic literature has become an increasingly daunting task. The time constraints facing dermatologists (and all physicians) have multiplied, as have administrative demands, burdens of electronic records, etc., challenging even the most time-efficient, organized

March 20, 2023 AAD/A Board of Directors agenda

AAD Heard from the Field DI Dr. Kaufmann Verbal A.

Agenda of the July 23, 2022 AAD/A Board of Directors meeting.

AAD Heard from the Field DI Dr. Kaufmann Verbal VII.

PDF of Nominating Committee Member Rep. Regional Map

the PE WEST REGION OF THE UNITED STATES QC ON AND CANADIAN PROVINCES ONLY NS (Shown in Pink) ND WA

PDF of Board of Directors Regional Map

NL 9 BC 40 NL AB SK MB 9 47 4 12 PE QC 1 ON 64 NS 140 20 WA ND MT NB 333 46 22

Academy physician leaders meet with federal legislators

On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...

2025 AAD Innovation Academy Attendee Statistics

Innovation Academy Attendance over the years: 2024 – Seattle, WA ..................................

AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair

Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health

Agenda for the Nov. 5, 2022 meeting of the AAD and AADA Board of Directors meetings.

AAD Heard from the Field DI Dr. Kaufmann Verbal VIII.

2024 AAD Innovation Academy | Official exhibitor suppliers

Experient) is the official housing provider for the 2024 AAD Innovation Academy Meeting in Seattle, WA

PDF of Unconscious Bias Proccedings AAMC 2017

Unconscious biases are di"erent from—and more di&cult to address than—known or explicit biases individuals

DI&I encore: Better than a back scratcher?

By Warren R. Heymann, MD March 30, 2017 The potential toxicity of the combination of topical ketamine/amitriptyline/lidocaine (TKAL) was discussed in a recent entry detailing the encephalopathic findings in an octogenarian Parkinsonian man with atopic dermatitis who was treated with the compound. I concluded: "As our therapeutic options for recalcitrant

Medical research funding

Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top

Not just for boys: X-linked erythropoietic protoporphyria

By Warren R. Heymann, MD Sept. 7, 2017 I was anxiously awaiting the results of erythrocyte protoporphyrin levels obtained from a 4 year-old boy who avoids sunlight because his "skin hurts" when not in the shade. Until I read the article by Balwani, et al (1), I was unaware of

Becoming pro-geriatric by understanding progeria

By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely

PDF of BGP Restrictions on Nomination Election Entities

The Assistant Secretary-Treasurer and/or staff will contact the c an di dates ’ post-election and advise

PDF of BF transplant dermatology

Am J Transplant. 2017 Nov;17(11):2782-2789. doi: 10.1111/ajt.14337. Epub 2017 May 30.

Advocacy Update Feb. 4 2025

IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC

PDF of The Impact of Unconscious Bias in HealthCare Marcelin 2019

"ese learning associations may be based on true towards di$erent social groups [20] prevalence rates

Dupilumab: The first year

By Warren R. Heymann, MD  ... Jan. 8, 2018 A patient with severe atopic dermatitis has benefited from dupilumab. ... Credit: Warren R Heymann ... When introduced as dermatologist to a new acquaintance, I’m sure you have heard: "Dermatology is a great field — you don’t cure anybody, so

Advocacy Update Dec 9, 2025

IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,

Taking the challenge: Social media, adolescents, and the skin

By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the

PS-Joint Position Statement on Buffered Lidocaine

If a PEC is used, all interior surfaces of the PEC should be cleaned and disinfected at the beginning

Advocacy Update Feb. 18 2025

IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to

Advocacy Update Mar. 18, 2025

IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key

PDF of authorization

DI SCLOSURE REGARDI NG BACKGROUND INVESTIGATION IMPORTANT -- PLEASE READ CAREFULLY BEFORE SIGNING

PDF of Authorization

DI SCLOSURE REGARDI NG BACKGROUND INVESTIGATION IMPORTANT -- PLEASE READ CAREFULLY BEFORE SIGNING

PDF of authorization for background check

DI SCLOSURE REGARDI NG BACKGROUND INVESTIGATION IMPORTANT -- PLEASE READ CAREFULLY BEFORE SIGNING

Surviving and thriving after a natural disaster

Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us

As molecular knowledge of PROS expands, lesions contract

By Warren R. Heymann, MD April 19, 2018 PIK3CA patient showing hemifacial hypertrophy. ... Credit: ... JAAD Somatic activating mutations in the phosphatidylinositol-3-kinase/AKT/mTOR pathway manifest as heterogeneous segmental overgrowth phenotypes Historically, the clinical diagnoses in patients with PIK3CA activating mutations have included Fibroadipose Hyperplasia or Overgrowth (FAO), Hemihyperplasia Multiple Lipomatosis

The concept of atrophoderma of pasini and pierini as morphea may be falling off a cliff

By Warren R. Heymann, MD Nov. 6, 2017 ... Clinical photos of idiopathic atrophoderma of Pierini and Pasini. ... Credit: ... JAAD Diagnosing Atrophoderma of Pasini and Pierini (APP) is reasonably straightforward — it usually presents in adolescents and young adults, more often in females, with sharply defined, single or

PDF of Histiocytosis

Kornik RI, Naik HB, Lee CC, Estrada-Veras J, Gahl WA, Cowen EW.

Glucose monitors: Not as sweet as they seem

By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial

PDF of autoimmune bullous dermatoses

Tampoia M, Giavarina D, Di Giorgio C, et al.

Radical chik: Chikungunya fever presenting as a toxic epidermal necrolysis-like eruption

By Warren R. Heymann, MD June 25, 2018 ... Chikungunya fever: morbilliform rash with islands of sparing. Photograph courtesy of Zawar Vijay, MD, Nashik, India. ... Credit: ... JAAD I have seen only one documented case of Chikungunya fever (CF), in a young woman who returned from Puerto Rico, presenting

Dupilumab’s conjunctivitis conundrum

By Warren R. Heymann, MD June 11, 2018 Having worn glasses since kindergarten, and being virtually helpless without them, I am particularly sympathetic to patients with eye disorders. ... Ocular disease in atopic dermatitis (AD) may manifest in a variety of ways. Conjunctivitis, a predisposition to keratoconus, and anterior subcapsular

PS-Nickel Sensitivity

Di Agosta E, Salvati L, Corazza M, et al.

Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome

By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was

Clawing to understand lichen nitidus

By Warren R. Heymann, MD April 5, 2018 Lichen nitidus: dermoscopic images. A, In the first patient, dermoscopic findings of the left plantar lesions revealed that linear scales in parallel (thick arrows) were discontinued by oval, well-defined depressions surrounded by ring-shaped, silvery white scales (thin arrows). Long axis of the

PD1 blockade: The next step for aggressive basal cell carcinomas?

By Warren R. Heymann, MD April 19, 2017 I was about to start the weekend, relishing that delightful TGIF feeling, with one final task — go through lab reports in my bin. My mood became morose when I read the follow-up letter about Sue (not her real name). She

2020 Legislative Conference Overview of Asks

Suzan DelBene, D-WA, Mike Kelly, R-PA, Ami Bera, MD, D-CA, and Roger Marshall, MD, R-KS.

Key messages to communicate about Indoor tanning

Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger

Hand-wringing over the histology of mechanic’s hands and other cutaneous manifestations of dermatomyositis

By Warren R. Heymann, MD April 23, 2018 Dermatomyositis. Erythematous papules overlying the metacarpal and interphalangeal joints (Gottron papules). ... Credit: ... JAAD Of all the cutaneous manifestations of dermatomyositis (DM) — the heliotrope rash, Gottron’s papules, Gottron’s sign, shawl sign, holster sign, flagellate erythema, photosensitivity, poikiloderma, periungual erythema, periungual

Voriconazole prophylaxis mandates cutaneous prophylaxis – and communication

By Warren R. Heymann, MD Sept. 28, 2017 The utilization of allogeneic hematopoietic stem cell transplantation (HSCT) has been increasing dramatically. According to the Health Resources and Services Administration, 92,784 procedures were performed between 2010 and 2014. ... Invasive fungal infections (IFIs) following allogeneic hematopoietic stem cell transplantation HSCT remain

COVID-19 dermatology registry

Thank you for agreeing to take part in this important effort on behalf of the American Academy of Dermatology and the International League of Dermatologic Societies. Our hope is that information you and others provide will help us understand dermatologic manifestations of the COVID-19 virus, as well as skin reactions

Key messages for social media about nails and nail health

Key messages ... Our nails often reflect our general state of health. Changes such as discoloration or thickening can signal health problems, including liver and kidney disease, heart and lung conditions, anemia, and diabetes. ... Changes in color, shape, and/or thickness, swelling of the skin around the nails, bleeding or

Nov. 6, 2021 AAD/AADA Board Agenda

AAD Heard from the Field DI Dr. Tomecki Verbal VII.

The profound dermatological manifestations of COVID-19: Part II

By Warren R. Heymann, MD March 25, 2020 Vol. 2, No. 12 Disclaimers: This commentary was written on March 17, 2020 for a publication date of March 25, 2020. The issues related to the COVID-19 pandemic are changing like lightning. The content included in this commentary may no longer be

Coming to terms with Louis Brocq and his diagram: Pityriasis lichenoides 2018

By Warren R. Heymann, MD July 16, 2018 ... A and B, Pityriasis lichenoides chronica–like drug eruption. The lower legs show several, 3- to 4-mm, red-brown, thin papules with centrally adherent micaceous scale and intermixed erosions. ... Credit: ... JAAD As a first-year dermatology resident in 1980, I struggled with

2024 AAD Annual Meeting Sponsorship Prospectus

sponsorships are also available for the 2024 AAD Innovation Academy (formerly Summer Meeting) in Seattle, WA

PDF of Eponyms in dermatology

erythroderma, spastic café-au-lait macule(s), polyostotic fibrous Hereditary Hemorrhagic Telangiectasia di-tetraplegia

Positively perplexing: Determining the meaning of CD30 positivity

By Warren R. Heymann, MD, FAAD Sept. 29, 2021 Vol. 3, No. 39 I’ll wager that most readers of DWI&I have experienced receiving a biopsy report, obtained from an inflammatory lesion, stating "scattered CD30+ cells were observed," accompanied by a comment that "clinicopathologic correlation is necessary to rule out the

Getting a head up on cutaneous scalp malignancies

By Warren R. Heymann, MD, FAAD May 7, 2025 Vol. 7, No. 18 I’m confident that your alopecic patients with a suspected keratinocyte carcinoma or melanoma of the scalp jokingly ask you to be careful with your biopsy procedure so they do not lose any more hair. While patients and

Biotin supplementation for hair and nail health: Does it pass the test?

By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,

After 23 years, a syndrome converted me into an eflornithine believer

By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.

Targeted anti-complement therapy may prove to be a complementary treatment for bullous pemphigoid

By Warren R. Heymann, MD Oct. 7, 2020 Vol. 2, No. 40 It is not my imagination — I have been seeing more cases of bullous pemphigoid (BP) than ever. This is likely a function of an aging population in concert with an increase of drug-induced cases, notably with dipeptidyl

Keeping up is hard to do: The need for true grit

By Warren R. Heymann, MD Oct. 5, 2017 One of the daunting challenges in practicing dermatology (or any branch of medicine) is keeping abreast of advances in the literature to optimize patient care. As a clinician-educator, I have always had an interest in how we learn best. For full disclosure,

Lipschütz ulcers: Not only for women

By Warren R. Heymann, MD March 24, 2021 Vol. 3, No. 12 Superstar dermatologists do not throw softball questions to presenters at the Annual Meeting of the American Academy of Dermatology. A few years ago, following my presentation on the cutaneous manifestations of Epstein-Barr infection, Dr. Jeffrey Callen, one of

JAK inhibitors battle in the heavyweight class

By Warren R. Heymann, MD, FAAD Nov. 12, 2025 Vol. 7, No. 45 Editor’s Note: A modified version of this commentary appeared as "A Clinician’s Perspective" in JAAD ... . JAK inhibitors (JAKi) have catapulted to such prominence in dermatologic therapeutics that I could write a weekly commentary about them.

PS-Climate and Health

Romanello M, Di Napoli C, Drummond P, et al.

Reflections on reflectance confocal microscopy for diagnosing benign lichenoid keratoses

By Warren R. Heymann, MD, FAAD July 5, 2023 Vol. 5, No. 27 At the inception of my dermatology residency in July 1980 I read a brief article entitled "Benign Lichenoid Keratosis" (BLK) by Detlef Goette (1) and thought to myself "Remember this — I’ll probably see this lesion now

The woolly culprit: Lanolin revealed as an uncommon cause of dermatitis on normal skin

By Christen Mowad, MD, FAAD Nov. 15, 2023 Vol. 5, No. 46 Excitement surrounding the "Allergen of the Year" may only be truly appreciated by those immersed in the field of contact dermatitis and patch testing, but each year the announcement is met with enthusiasm from the wider dermatology specialty.

The pressure to prevent pressure ulcers

By Warren R. Heymann, MD, FAAD Aug. 24, 2022 Vol. 4, No. 34 Pressure ulcers (PUs, aka decubitus ulcers, pressure sores, bed sores) are due to prolonged pressure, characteristically over bony prominences such as the sacrum, occiput, ischial tuberosities, greater trochanters, heels, and lateral malleoli. (1,2) Interestingly, in the COVID-19

Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon

By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive

PDF of Update in melanoma theories

Di Franco S, Turdo A, Todaro M, Stassi G.

Necrobiosis lipoidica in a Wink

By Warren R. Heymann, MD, FAAD May 3, 2023 Vol. 5, No. 18 Ninety years have transpired since Urbach coined the term ... necrobiosis lipoidica diabeticorum (NLD) for the granulomatous disorder first described by Oppenheim in 1929 as ... dermatitis atrophicans lipoidica diabetica . (1) Early authors observed sclerotic plaques

Recognizing toxic epidermal necrolysis-like acute cutaneous lupus erythematosus ASAP

By Warren R. Heymann, MD, FAAD November 10, 2021 Vol. 3, No. 45 ASAP, the well-recognized acronym for "as soon as possible," takes on special significance for dermatologists confirming the diagnosis of toxic epidermal necrolysis (TEN). In 2004, Ting et al introduced an alternative definition of the ASAP acronym —

Which treatment modality of pyogenic granuloma is worth its weight in salt?

By Warren R. Heymann, MD, FAAD July 31, 2024 Vol. 6, No. 31 I get palpitations with every pyogenic granuloma (PG) I encounter. Even though the clinical diagnosis is instant, my personal Jiminy Cricket dermatologist reminds me not to miss an amelanotic melanoma, squamous cell carcinoma, or cutaneous metastasis. If

Tag, you’re it!

By Warren R. Heymann, MD, FAAD Sept. 28, 2022 Vol. 4, No. 39 Chances are you will see a patient with skin tags today. ... Patients will likely ask you two questions: Why do I get them? What do you mean my insurance won’t cover their removal (for asymptomatic lesions)?

Further dermatologic observations in cystic fibrosis

By Warren R. Heymann, MD, FAAD Aug. 6, 2025 Vol. 7, No. 31 Watson: And yet I believe that my eyes are as good as yours. Holmes: Quite so. You see, but you do not observe... – Sherlock Holmes in "A Scandal in Bohemia" (1891, written by Sir Arthur Conan

The aryl hydrocarbon receptor: Tapinarof is taking off

By Warren R. Heymann, MD, FAAD Nov. 19, 2025 Vol. 7, No. 46 In his outstanding lecture identifying drivers of lupus, presented at the 2025 meeting of the Medical Dermatology Society, Jaehyuk Choi MD, PhD, explained that interferon — the well-known nemesis of lupus — controls the production of T

PDF of AD guidelines on phototherapy supplement

JAK Inhibitors Adapted from: Drucker AM, Morra DE, Prieto-Merino D, Ellis AG, Yiu ZZN, Rochwerg B, Di

PDF of Nail disease

Vinson, Iron deficiency, hemochromatosis, Amy Reinstadler, MDp ahynd Nsiologaicz inani chn Sildreane di

The nexus of VEXAS syndrome

By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS

Reflections on infantile perianal pyramidal protrusion and Hippocrates

By Warren R. Heymann, MD, FAAD May 29, 2024 Vol. 6, No. 22 Patient safety and quality improvement have been at the forefront of medical care since the publication of "To Err is Human: Building a Safer Health System" by the Institute of Medicine, which estimated that as many as

AAD Innovation Academy 2020 Technical Exhibitor Prospectus

Friday. 70 Pike St., Seattle, WA 98101 Welcome Reception (Exhibits Open) 3 Thursday, August 13 ......

Cycling back to doxycycline’s roots as therapy for bullous pemphigoid

By Warren R. Heymann, MD, FAAD July 26, 2023 Vol. 5, No. 30 Patients with moderate to severe bullous pemphigoid are usually treated with systemic corticosteroids. Four patients were treated with tetracycline hydrochloride and niacinamide because of the steroid-sparing anti-inflammatory properties of these agents. An excellent clinical response free of

Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease

By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with

Indoor tanning fact sheet

Indoor tanning use  ... The global prevalence of indoor tanning in adolescents for 2013-2018 was 6.5%, and 10.4% in adults. (1) ... Though the numbers have been decreasing in recent years, approximately 7.8 million adults in the U.S. still engage in indoor tanning. (2,3) ... Among high school students in

PDF of AAD Atopic Dermatitis pediatric comorbid conditions guideline draft

Berni Canani R, Di Costanzo M, Bedogni G, Amoroso A, Cosenza L, Di Scala C et al. 562 Extensively hydrolyzed

PDF of proposed guidelines on AD and phototherapy

Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB , Corrocher R.

PDF of Spring 2020 issue of DW Directions in Residency

Tampoia M, Giavarina D, Di Giorgio C, et al.

PDF of gross and micro abstract programs

Sa NB, Guerini MB, Barbato MT, Di Giunta G, Nunes DH.

PDF of AAD Atopic Dermatitis pediatric comorbid conditions supplement draft

Berni Canani R, Di Costanzo M, Bedogni G, Amoroso A, Cosenza L, Di Scala C et al.

PDF of AAD Atopic Dermatitis pediatric guideline draft

Tripodi S, Di Rienzo Businco A, Panetta V, et al.

2023 Annual Meeting Technical Exhibit Prospectus

ORLEANS, LA• March 17-21, 2023 TAMPA, FL• August 10-13, 2023 SAN DIEGO, CA • March 8-12, 2024 SEATTLE, WA

The first edition of the AAD/A Impact Report

Graff, MD, FAAD* Anna Di Nardo, MD, PhD Z.

PDF of AAD Atopic Dermatitis pediatric supplement draft

Tripodi S, Di Rienzo Businco A, Panetta V, Pingitore G, Volterrani A, Frediani T et al.